Atlas Trials

Study of the Duration and Efficacy of MYDAYIS on Adult ADHD Symptoms and Executive Function Throughout the Day Into the Early Evening

Clinical trial NCT03945175 · COMPLETED

Trial details

NCT number
NCT03945175
Sponsor
NYU Langone Health
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Attention Deficit-Hyperactivity
Start date
2020-07-15
Primary completion
2022-05-11
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.